| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.057 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |